Revolution Medicines, Inc. financial data

Symbol
RVMD on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
700 Saginaw Dr, Redwood City, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.33K % +23.4%
Debt-to-equity 13.3 % -28.8%
Return On Equity -36.4 % +1.03%
Return On Assets -32.1 % -3.65%
Operating Margin -12.1K % -1430%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 165M shares +55.2%
Common Stock, Shares, Outstanding 165M shares +55.1%
Entity Public Float 2.76B USD +124%
Common Stock, Value, Issued 16K USD +45.5%
Weighted Average Number of Shares Outstanding, Basic 165M shares +73.7%
Weighted Average Number of Shares Outstanding, Diluted 165M shares +73.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 4.57M USD -86.9%
Research and Development Expense 472M USD +77.8%
General and Administrative Expense 85.2M USD +90.4%
Operating Income (Loss) -553M USD -101%
Nonoperating Income (Expense) 65.1M USD +309%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -488M USD -87.9%
Income Tax Expense (Benefit) -3.52M USD -739%
Net Income (Loss) Attributable to Parent -484M USD -86.9%
Earnings Per Share, Basic -3.84 USD/shares -27.2%
Earnings Per Share, Diluted -3.84 USD/shares -27.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 288M USD -32.5%
Marketable Securities, Current 1.42B USD +193%
Assets, Current 1.73B USD +87.4%
Property, Plant and Equipment, Net 23.7M USD +27.8%
Operating Lease, Right-of-Use Asset 76.2M USD +40.3%
Intangible Assets, Net (Excluding Goodwill) 57.5M USD -1.82%
Goodwill 14.6M USD 0%
Other Assets, Noncurrent 4.16M USD +50%
Assets 1.91B USD +77.8%
Accounts Payable, Current 32.4M USD +62.6%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 93.7M USD +71.5%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Deferred Income Tax Liabilities, Net 3.12M USD -55.7%
Operating Lease, Liability, Noncurrent 79.9M USD +38.5%
Other Liabilities, Noncurrent 3.04M USD +79.5%
Liabilities 183M USD +51.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.2M USD -115%
Retained Earnings (Accumulated Deficit) -1.25B USD -62.9%
Stockholders' Equity Attributable to Parent 1.73B USD +81.2%
Liabilities and Equity 1.91B USD +77.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -161M USD -157%
Net Cash Provided by (Used in) Financing Activities 810K USD -99.8%
Net Cash Provided by (Used in) Investing Activities -248M USD -6305%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 170M shares +60.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -408M USD -253%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 291M USD -32.1%
Deferred Tax Assets, Valuation Allowance 377M USD +68.1%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 404M USD +61.2%
Operating Lease, Liability 88M USD +38.4%
Depreciation 5.38M USD +25.7%
Payments to Acquire Property, Plant, and Equipment 3.17M USD +80.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -485M USD -87.6%
Lessee, Operating Lease, Liability, to be Paid 144M USD +32.1%
Property, Plant and Equipment, Gross 42.6M USD +24.5%
Operating Lease, Liability, Current 8.17M USD +38%
Lessee, Operating Lease, Liability, to be Paid, Year Two 10.8M USD +47.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 10.5M USD +47.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) -3.85M USD -816%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 55.6M USD +26%
Lessee, Operating Lease, Liability, to be Paid, Year Three 11.2M USD +47.5%
Deferred Tax Assets, Operating Loss Carryforwards 148M USD +11.7%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 0 USD
Current Income Tax Expense (Benefit) 324K USD
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 191M USD +2418%
Lessee, Operating Lease, Liability, to be Paid, Year Four 11.6M USD +47.5%
Operating Lease, Payments 2.3M USD -14.3%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 112K USD
Current Federal Tax Expense (Benefit) 0 USD
Amortization of Intangible Assets 1.07M USD -0.09%
Depreciation, Depletion and Amortization 1.21M USD +33.7%
Deferred Tax Assets, Net of Valuation Allowance 26.9M USD +2.39%
Share-based Payment Arrangement, Expense 68.3M USD +99.4%
Deferred State and Local Income Tax Expense (Benefit) -3.87M USD -820%
Interest Expense 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%